Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple Sclerosis

Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple Sclerosis

Introduction: The efficacy of anti-CD20 antibodies has significantly contributed to advancing our understanding of disease pathogenesis and improved treatment outcomes in relapsing-remitting multiple sclerosis (RRMS). A comprehensive analysis of the peripheral immune cell profile, combined with pros...

Full description

Saved in:
Bibliographic Details
Main Authors: Alice G. Willison, Ramona Hagler, Margit Weise, Saskia Elben, Niklas Huntemann, Lars Masanneck, Steffen Pfeuffer, Stefanie Lichtenberg, Kristin S. Golombeck, Lara-Maria Preuth, Leoni Rolfes, Menekse Öztürk, Tobias Ruck, Nico Melzer, Melanie Korsen, Stephen L. Hauser, Hans-Peter Hartung, Philipp A. Lang, Marc Pawlitzki, Saskia Räuber, Sven G. Meuth
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Cells
Subjects:
multiple sclerosis
autoimmunity
ocrelizumab
ofatumumab
immune reconstitution
Online Access:https://www.mdpi.com/2073-4409/14/7/552
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2073-4409/14/7/552

Similar Items